The global financial crisis left a permanent mark on our understanding of what it means to be prosperous, how to achieve prosperity as well as on future generations. At the Thursday, June 20th day of innovation at the International Arts & Ideas Festival in New Haven, Connecticut, join us for a discussion on: Global Innovators: From Recession to Prosperity.
Thomson Reuters 2012 Top 100 Global Innovators report is the foundation for this discussion focused on corporations and institutions around the world that are at the heart of innovation. Panelists will reflect on the study and discuss the direct correlation between innovation and economic prosperity, including the questions of:
Who are the leaders in innovation?
How does innovation help us overcome economic challenges?
How is innovation changing the world in which we live and work?
“For the last three years we’ve provided the data and analysis that powers the World University Rankings, the leading comparison of academic institutions. The annual publication by Times Higher Education (THE) assesses 400 universities’ performance against their core missions – teaching, research, knowledge transfer and international outlook.
THE aims to publish the most robust and credible global rating and their methodology must deliver this. Our expertise has helped them to better assess performance at a more granular level. For example, we’ve eliminated bias for subjects with higher funding and record the number of academic papers published per staff member rather than the total for the department or university.
It’s a truly global project. Increasingly, governments and the academic community use the rankings as geo-political indicator, helping them to understand the performance of their education policies and how well they’re responding to the demands of the knowledge economy. For example, in Australia the universities are very much like an export industry because lots of international students study there. And in Korea and China where they are investing heavily in education, it’s really valuable to be able to compare performance to other countries.
Our work with THE allows academic institutions to reach new audiences. The World University Rankings 2012-2013 is helping the THE website attract tens of millions of page views and Forbes, Huffington Post and BBC were among more than 550 publications to cover the latest rankings. The work also fits into our wider academic programs such as our Institutional Profiles Project.”
The pharmaceutical industry is experiencing change in ways it hasn’t ever before. On the demand side, we are seeing an aging population, increased prevalence of “Western” diseases, and a dramatic growth in global access to pharmaceuticals. On the supply side, we are seeing increased competition from emerging market players, and a shift in the way drugs are being developed, manufactured, and delivered. Meanwhile, policy makers are struggling with an inherent conflict between desire to provide improved access to better medicines and the need to curb the growth of healthcare expenditures.
One topic at the center of all of these changes is the U.S. biosimilars market. Biosimilar products will offer competition to some of the most expensive drugs on the market, but also require high investment. The promise of biosimilars in the U.S. is to provide cost savings, increase patient access, and promote innovation. And despite being a market still void of any entrants, the U.S. biosimilars market continues to attract attention.
The release of An Outlook on U.S. Biosimilar Competition report from the Thomson Reuters IP & Science provides a comprehensive view of the challenges facing companies entering the United States biosimilar market, and the key players predicted to break into this developing pharmaceutical space. The report examines the scientific and quality considerations within the U.S. FDA’s guidance document, as well as exclusivity policies, clinical trial experience, and global regulations to identify the challenges pharmaceutical companies face in establishing a U.S. market for biosimilar drugs.
Congratulations to Frank Schilder, Research Manager, Research & Development and Blake Howald, Research Scientist, Research & Development, winners of the 2012 Thomson Reuters Inventor Award for their patent, Systems and Methods for Natural Language Generation. Their patent was selected from among all patents filed by Thomson Reuters in 2012.
15 May 2013Thomson Reuters
What is the Inventor Awards program?
The annual Thomson Reuters Inventor Awards program recognizes and rewards employees who have submitted patent applications during the past year. Patents are critical to protecting Thomson Reuters intellectual property, including technology solutions and improvements to products or processes.
Our global conference coverage team is made up of scientific specialists and industry professionals. They understand you want comprehensive coverage and you want it now. Which is why we promise to deliver full reports within 28 days of a conference ending — but average 14. Be the first to act on the latest drug pipeline and patents information — with broad conference coverage from Cortellis for Competitive Intelligence.
When it comes to the year in trademarks, the U.K. and Turkey had the strongest growth, China came out ahead of the U.S. and Italy is not the fashion capital of the world. Judging soley on the number of clothing, footwear and headgear trademarks, China is. Check out a new report from our IP & Science business which tracked activity and identified trends across the world’s largest collection of trademark databases.
What does opportunity look like? Across the industries we serve, we help our customers identify the fundamental forces and changes that affect their worlds.The following story from our 2012 Annual Report uses the power of data visualization to simplify and unify complex sets of data, and illustrate the ways in which the ability to see and understand change can reveal powerful opportunities. (more…)
It’s all over except for the joy of the victor, and the agony of the rest. The University of Louisville may have won this year’s NCAA Men’s Basketball Championship, but in Metrics Mania, a first-of-its-kind competition measuring the research impact of American universities participating in the NCAA college competition, the real winner is the University of California Berkeley. Berkeley narrowly defeated Harvard by one-hundredth of a point in the final face-off of the tournament. So close, Crimson, so close! (more…)
We are pleased to launch our online 2012 Annual Report, which highlights how our business helps customers to turn Change into Opportunity.
In addition to providing information on our financial performance, this year’s annual report uses the power of data visualization to explore five issues impacting our world today. From understanding the dynamics of market sentiment to mapping the evolving legal landscape, our information and tools help customers to understand the changes that are transforming their industries, and to uncover important new opportunities.
Innovation and change have always been key components of any successful company. You need to be different if not ground-breaking in order to get ahead. The 2012 State of Innovation tracks who’s leading the way in patent activity using the Thomson Reuters Derwent World Patents Index database.
Patents are really a proxy for innovation. Inventive ideas that are unprotected can’t be successfully commercialized. Therefore, by looking at patent activity, one gets a true picture of the innovative landscape, regardless of how commercially successful an invention is.
18 Jun 2013
THE aims to publish the most robust and credible global rating and their methodology must deliver this. Our expertise has helped them to better assess performance at a more granular level. For example, we’ve eliminated bias for subjects with higher funding and record the number of academic papers published per staff member rather than the total for the department or university.
